BeOne Medicines
ONC
#755
Rank
ยฃ24.05 B
Marketcap
ยฃ216.47
Share price
-0.48%
Change (1 day)
12.39%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Earnings for BeOne Medicines (ONC)

Earnings in 2025 (TTM): ยฃ0.35 Billion

According to BeOne Medicines's latest financial reports the company's current earnings are ยฃ5.34 Billion. , an increase over its 2024 earnings that were of -ยฃ0.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BeOne Medicines from 2015 to 2025

Annual earnings

Year Earnings Change
2025 ยฃ0.34 B-183.61%
2024 -ยฃ0.42 Billion-52.95%
2023 -ยฃ0.89 Billion-32.52%
2022 -ยฃ1.32 Billion24.39%
2021 -ยฃ1.06 Billion-13.21%
2020 -ยฃ1.23 Billion72.69%
2019 -ยฃ0.71 Billion36.01%
2018 -ยฃ0.52 Billion616.83%
2017 -ยฃ72.53 Million-15.24%
2016 -ยฃ85.58 Million107.91%
2015 -ยฃ41.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-ยฃ0.12 Billion-133.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-ยฃ13.38 Million-103.82%๐Ÿ‡บ๐Ÿ‡ธ USA